ZIVO Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-11.3M | $137.9K |
| FY2021 | — | $6.0M | $8.9M |
| FY2022 | — | $-10.6K | $1.8M |
| FY2023 | — | $-2.2M | $274.4K |
| FY2024 | — | $-514.9K | $1.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-11.3M | $137.9K |
| FY2021 | — | $6.0M | $8.9M |
| FY2022 | — | $-10.6K | $1.8M |
| FY2023 | — | $-2.2M | $274.4K |
| FY2024 | — | $-514.9K | $1.5M |